Displaying 1 - 12 items out of 32 results
Landing page
… Inhibitors Chris Martin +more Sep 09, 2025 Press release Circulating Tumor DNA May Guide Immunotherapy Use in Limited-Stage SCLC, New …
ILCN article
Using Early ctDNA, Study Findings Inform Prognostic Model
… PhD, at the 2025 World Conference on Lung Cancer, evaluated circulating tumor DNA (ctDNA) as a predictive biomarker for consolidation …
Landing page
… NSCLC Haleigh Behrman Nov 04, 2025 ILCN article Using Early ctDNA, Study Findings Inform Prognostic Model Haleigh Behrman … JTO The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015 Ming S. Tsao +more Nov …
Landing page
… JTO The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015 Ming S. Tsao +more Nov … JTO The 2021 World Health Organization Classification of Tumors of the Thymus and Mediastinum: What’s new in thymic epithelial, germ cell and mesenchymal tumors? A. Marx +more Oct 21, 2021 Explore Our Journals …
Press release
… on Lung Cancer (WCLC) demonstrates that monitoring circulating tumor DNA (ctDNA) can refine and personalize the use of …
Press release
… 2021, 9 a.m. GMT/10 a.m. CDT/11 a.m. EDT) --Pre-treatment circulating tumor (ct)DNA levels more accurately predicted long-term survival than …
Press release
… PD-L1 inhibition overcomes T-cell suppression at the tumor; and chemotherapy causes tumor cell death and antigen … molecularly characterized via sequencing of tumor tissue DNA and/or circulating tumor DNA samples. Progression free survival and …
Press release
… Barcelona— Tumor mutational burden was not significantly associated … Garassino from theFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Dr. Garassino presented this new data … by whole-exome sequencing of tumor and matched normal DNA. The clinical utility of TMB on outcomes was assessed …
Press release
… services to cancer research. Her research interests span tumor biology, biomarker discovery, preclinical … Biomarker Research program, she became fascinated with circulating tumor cells (CTCs) for use as a liquid biopsy. … proud that some of the earliest work on circulating tumor DNA (ctDNA) done with AstraZeneca and Professor Andrew …
ILCN article
The Promise of Artificial Intelligence-Aided Pathology in Thoracic Oncology
… Assessment of tumor material by the pathology laboratory has become a … who must maintain in-depth knowledge of rapidly changing tumor classification and staging systems as well as of … The detection of targetable genomic alterations by DNA and RNA sequencing has become a mainstay for prediction …
Landing page
… for Research and Education Brazil Project: Genome-wide DNA Methylation Analysis in Patients with EFGR-mutant Lung … Project: Targeting Phagocytosis Regulators to Enhance Anti-Tumor Immunity in Small Cell Lung Cancer Image Komal … States Project: Development of a Gene Signature Linking Tumor-Reactive TIL Spatial Interactions Related to …
Press release
… complex malignancy. Liquid biopsy, and especially plasma ctDNA, can be used in many clinical settings where tissue is … that IASLC is in the forefront in this arena.” Although tumor tissue is historically the gold standard biospecimen … biopsy approach includes a variety of methodologies for circulating analytes. From a clinical point of view, plasma …